SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Qualified Opinion who wrote (3144)8/26/2002 8:45:46 AM
From: Qualified Opinion  Read Replies (1) of 10345
 
Elan shares up again on upgrade

Shares in Elan continued their recent recovery in Dublin today as NCB Stockbrokers upgraded the company from 'reduce' to 'hold'. The shares were up 33 cent - nearly 10%5 - to €3.75 just before lunchtime.

NCB reviewed its recommendation following the implementation of a recent restructuring programme announced by new chairman Garo Armen.

The note said NCB viewed the programme and the aggressive measures taken to address the upcoming funding problems as positives, though it described the target of raising $1.5 billion in cash as ambitious. It said revenue targets appeared to be realistic.

Analysts David Marshall and Orla Hartford said Elan's recent strong share performance appears to have been driven by rumours of a takeover approach, but they believe any move is unlikely until the SEC has completed its probe into the company and the restructuring plan has progressed further.

onbusiness.ie
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext